- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Calico Life Sciences LLC
Headquarters: South San Francisco, CA, United States
Website: https://www.calicolabs.com/
Year Founded: 2013
Status: Private
BioCentury | Oct 18, 2024
Finance
KdT closes new $100M+ fund; portfolio company Terray draws $120M series B
BioCentury’s Venture Report also includes fundings for Nuclera, TenNor, Shift, Tolerance and Sunbird
BioCentury | Mar 28, 2024
Management Tracks
George Eliades at the helm of Mythic
Plus: Michael Lenardo to become CSO at Calico, and updates from Aveo and Dyadic
BioCentury | Dec 21, 2023
Management Tracks
Larson leaving LianBio as CFO
Plus: Claypoole becomes CEO of Bioventus, and updates from Boston Pharma, Atlas, Quest, Scribe, 858 and more
BioCentury | Oct 6, 2023
Discovery & Translation
An AbbVie-Calico cancer therapy; plus Moderna’s monkeypox vaccine and more
BioCentury’s roundup of translational innovations
BioCentury | Jun 29, 2022
Management Tracks
New CEOs at Dunad and Cargene
Plus Vickers becomes CEO at MSKCC, and updates from Paradigm and DTx
BioCentury | May 17, 2022
Discovery & Translation
Lurie winners’ epigenetic view into the biology of aging diseases
Anne Brunet and Andrew Dillin’s multispecies research highlights epigenetic and mitochondrial biology that could underlie constellations of diseases
BioCentury | Jan 20, 2022
Product Development
Barron’s departure leaves unfinished business in GSK’s cancer pipeline
CSO stepping down to join biopharma ‘dream team’ at newly launched Altos
BioCentury | Sep 10, 2021
Targets & Mechanisms
Integrated stress response key to seemingly disparate diseases?
A flurry of preclinical studies builds the case for the integrated stress response as a central driver of many diseases
BioCentury | Jul 28, 2021
Deals
July 27 Quick Takes: Three times and it’s still charming for AbbVie, Calico
Light demand for Candel IPO, plus Keytruda, AC Immune, Relmada, Regeneron-AstraZeneca
BioCentury | Feb 9, 2021
Translation in Brief
A sickle cell disease gene therapy; plus a dengue virus inhibitor, a small molecule to enhance memory in Alzheimer’s and a cytokine that mediates synaptic function
BioCentury’s roundup of translational news
Items per page:
1 - 10 of 34